nodes	percent_of_prediction	percent_of_DWPC	metapath
Aciclovir—SLC47A2—Mitoxantrone—lymphatic system cancer	0.525	0.604	CbGbCtD
Aciclovir—SLC47A1—Mitoxantrone—lymphatic system cancer	0.218	0.251	CbGbCtD
Aciclovir—SLC22A1—Cytarabine—lymphatic system cancer	0.0851	0.0979	CbGbCtD
Aciclovir—SLC22A8—Methotrexate—lymphatic system cancer	0.0241	0.0277	CbGbCtD
Aciclovir—SLC22A6—Methotrexate—lymphatic system cancer	0.0168	0.0193	CbGbCtD
Aciclovir—Vasculitis—Methotrexate—lymphatic system cancer	0.000324	0.00248	CcSEcCtD
Aciclovir—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000323	0.00247	CcSEcCtD
Aciclovir—Urethral disorder—Vincristine—lymphatic system cancer	0.000321	0.00246	CcSEcCtD
Aciclovir—Eye disorder—Carmustine—lymphatic system cancer	0.00032	0.00245	CcSEcCtD
Aciclovir—Hypersensitivity—Teniposide—lymphatic system cancer	0.000319	0.00244	CcSEcCtD
Aciclovir—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000319	0.00244	CcSEcCtD
Aciclovir—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000317	0.00243	CcSEcCtD
Aciclovir—Anaemia—Bleomycin—lymphatic system cancer	0.000316	0.00242	CcSEcCtD
Aciclovir—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000314	0.0024	CcSEcCtD
Aciclovir—Asthenia—Teniposide—lymphatic system cancer	0.000311	0.00238	CcSEcCtD
Aciclovir—Malaise—Bleomycin—lymphatic system cancer	0.000308	0.00236	CcSEcCtD
Aciclovir—Pruritus—Teniposide—lymphatic system cancer	0.000306	0.00234	CcSEcCtD
Aciclovir—Leukopenia—Bleomycin—lymphatic system cancer	0.000306	0.00234	CcSEcCtD
Aciclovir—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.000305	0.00234	CcSEcCtD
Aciclovir—Alopecia—Carmustine—lymphatic system cancer	0.000303	0.00232	CcSEcCtD
Aciclovir—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000302	0.00231	CcSEcCtD
Aciclovir—Body temperature increased—Fludarabine—lymphatic system cancer	0.000301	0.0023	CcSEcCtD
Aciclovir—Erythema—Carmustine—lymphatic system cancer	0.000298	0.00228	CcSEcCtD
Aciclovir—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000297	0.00227	CcSEcCtD
Aciclovir—Diarrhoea—Teniposide—lymphatic system cancer	0.000296	0.00227	CcSEcCtD
Aciclovir—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000295	0.00226	CcSEcCtD
Aciclovir—Chest pain—Bleomycin—lymphatic system cancer	0.000291	0.00223	CcSEcCtD
Aciclovir—Myalgia—Bleomycin—lymphatic system cancer	0.000291	0.00223	CcSEcCtD
Aciclovir—Alopecia—Vincristine—lymphatic system cancer	0.000289	0.00221	CcSEcCtD
Aciclovir—Coma—Methotrexate—lymphatic system cancer	0.000289	0.00221	CcSEcCtD
Aciclovir—Discomfort—Bleomycin—lymphatic system cancer	0.000288	0.0022	CcSEcCtD
Aciclovir—Chills—Mitoxantrone—lymphatic system cancer	0.000286	0.00219	CcSEcCtD
Aciclovir—Alopecia—Mitoxantrone—lymphatic system cancer	0.000282	0.00216	CcSEcCtD
Aciclovir—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000281	0.00215	CcSEcCtD
Aciclovir—Confusional state—Bleomycin—lymphatic system cancer	0.000281	0.00215	CcSEcCtD
Aciclovir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00028	0.00215	CcSEcCtD
Aciclovir—Tremor—Carmustine—lymphatic system cancer	0.00028	0.00214	CcSEcCtD
Aciclovir—Oedema—Bleomycin—lymphatic system cancer	0.000279	0.00214	CcSEcCtD
Aciclovir—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000279	0.00214	CcSEcCtD
Aciclovir—Erythema—Mitoxantrone—lymphatic system cancer	0.000277	0.00212	CcSEcCtD
Aciclovir—Anaemia—Carmustine—lymphatic system cancer	0.000276	0.00211	CcSEcCtD
Aciclovir—Vomiting—Teniposide—lymphatic system cancer	0.000275	0.00211	CcSEcCtD
Aciclovir—Agitation—Carmustine—lymphatic system cancer	0.000274	0.0021	CcSEcCtD
Aciclovir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000273	0.00209	CcSEcCtD
Aciclovir—Asthenia—Fludarabine—lymphatic system cancer	0.000273	0.00209	CcSEcCtD
Aciclovir—Rash—Teniposide—lymphatic system cancer	0.000273	0.00209	CcSEcCtD
Aciclovir—Dermatitis—Teniposide—lymphatic system cancer	0.000273	0.00209	CcSEcCtD
Aciclovir—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000272	0.00208	CcSEcCtD
Aciclovir—Headache—Teniposide—lymphatic system cancer	0.000271	0.00208	CcSEcCtD
Aciclovir—Pruritus—Fludarabine—lymphatic system cancer	0.000269	0.00206	CcSEcCtD
Aciclovir—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000269	0.00206	CcSEcCtD
Aciclovir—Leukopenia—Carmustine—lymphatic system cancer	0.000267	0.00204	CcSEcCtD
Aciclovir—Anorexia—Bleomycin—lymphatic system cancer	0.000266	0.00204	CcSEcCtD
Aciclovir—Anaemia—Vincristine—lymphatic system cancer	0.000263	0.00202	CcSEcCtD
Aciclovir—Agitation—Vincristine—lymphatic system cancer	0.000262	0.002	CcSEcCtD
Aciclovir—Photosensitivity—Methotrexate—lymphatic system cancer	0.000261	0.002	CcSEcCtD
Aciclovir—Hypotension—Bleomycin—lymphatic system cancer	0.000261	0.002	CcSEcCtD
Aciclovir—Diarrhoea—Fludarabine—lymphatic system cancer	0.00026	0.00199	CcSEcCtD
Aciclovir—Convulsion—Carmustine—lymphatic system cancer	0.000259	0.00198	CcSEcCtD
Aciclovir—Hypertension—Carmustine—lymphatic system cancer	0.000258	0.00197	CcSEcCtD
Aciclovir—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000257	0.00197	CcSEcCtD
Aciclovir—Nausea—Teniposide—lymphatic system cancer	0.000257	0.00197	CcSEcCtD
Aciclovir—Anaemia—Mitoxantrone—lymphatic system cancer	0.000256	0.00196	CcSEcCtD
Aciclovir—Vertigo—Vincristine—lymphatic system cancer	0.000256	0.00196	CcSEcCtD
Aciclovir—Leukopenia—Vincristine—lymphatic system cancer	0.000255	0.00195	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000254	0.00195	CcSEcCtD
Aciclovir—Chest pain—Carmustine—lymphatic system cancer	0.000254	0.00194	CcSEcCtD
Aciclovir—Myalgia—Carmustine—lymphatic system cancer	0.000254	0.00194	CcSEcCtD
Aciclovir—Paraesthesia—Bleomycin—lymphatic system cancer	0.000251	0.00192	CcSEcCtD
Aciclovir—Malaise—Mitoxantrone—lymphatic system cancer	0.00025	0.00191	CcSEcCtD
Aciclovir—Dyspnoea—Bleomycin—lymphatic system cancer	0.000249	0.0019	CcSEcCtD
Aciclovir—Renal failure acute—Methotrexate—lymphatic system cancer	0.000249	0.0019	CcSEcCtD
Aciclovir—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000248	0.0019	CcSEcCtD
Aciclovir—Convulsion—Vincristine—lymphatic system cancer	0.000247	0.00189	CcSEcCtD
Aciclovir—Hypertension—Vincristine—lymphatic system cancer	0.000246	0.00188	CcSEcCtD
Aciclovir—Confusional state—Carmustine—lymphatic system cancer	0.000246	0.00188	CcSEcCtD
Aciclovir—Oedema—Carmustine—lymphatic system cancer	0.000244	0.00186	CcSEcCtD
Aciclovir—Decreased appetite—Bleomycin—lymphatic system cancer	0.000243	0.00186	CcSEcCtD
Aciclovir—Myalgia—Vincristine—lymphatic system cancer	0.000243	0.00186	CcSEcCtD
Aciclovir—Vomiting—Fludarabine—lymphatic system cancer	0.000242	0.00185	CcSEcCtD
Aciclovir—Convulsion—Mitoxantrone—lymphatic system cancer	0.00024	0.00184	CcSEcCtD
Aciclovir—Rash—Fludarabine—lymphatic system cancer	0.00024	0.00184	CcSEcCtD
Aciclovir—Dermatitis—Fludarabine—lymphatic system cancer	0.00024	0.00183	CcSEcCtD
Aciclovir—Hypertension—Mitoxantrone—lymphatic system cancer	0.00024	0.00183	CcSEcCtD
Aciclovir—Pain—Bleomycin—lymphatic system cancer	0.000239	0.00183	CcSEcCtD
Aciclovir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000238	0.00183	CcSEcCtD
Aciclovir—Headache—Fludarabine—lymphatic system cancer	0.000238	0.00182	CcSEcCtD
Aciclovir—Tachycardia—Carmustine—lymphatic system cancer	0.000238	0.00182	CcSEcCtD
Aciclovir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000236	0.00181	CcSEcCtD
Aciclovir—Chest pain—Mitoxantrone—lymphatic system cancer	0.000236	0.00181	CcSEcCtD
Aciclovir—Myalgia—Mitoxantrone—lymphatic system cancer	0.000236	0.00181	CcSEcCtD
Aciclovir—Lethargy—Methotrexate—lymphatic system cancer	0.000234	0.00179	CcSEcCtD
Aciclovir—Discomfort—Mitoxantrone—lymphatic system cancer	0.000233	0.00179	CcSEcCtD
Aciclovir—Oedema—Vincristine—lymphatic system cancer	0.000232	0.00178	CcSEcCtD
Aciclovir—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000232	0.00178	CcSEcCtD
Aciclovir—Anorexia—Carmustine—lymphatic system cancer	0.000232	0.00178	CcSEcCtD
Aciclovir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00023	0.00176	CcSEcCtD
Aciclovir—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00023	0.00176	CcSEcCtD
Aciclovir—Confusional state—Mitoxantrone—lymphatic system cancer	0.000228	0.00175	CcSEcCtD
Aciclovir—Nervous system disorder—Vincristine—lymphatic system cancer	0.000228	0.00175	CcSEcCtD
Aciclovir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000228	0.00174	CcSEcCtD
Aciclovir—Hypotension—Carmustine—lymphatic system cancer	0.000228	0.00174	CcSEcCtD
Aciclovir—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000226	0.00173	CcSEcCtD
Aciclovir—Oedema—Mitoxantrone—lymphatic system cancer	0.000226	0.00173	CcSEcCtD
Aciclovir—Nausea—Fludarabine—lymphatic system cancer	0.000226	0.00173	CcSEcCtD
Aciclovir—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000225	0.00172	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000222	0.0017	CcSEcCtD
Aciclovir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000222	0.0017	CcSEcCtD
Aciclovir—Urticaria—Bleomycin—lymphatic system cancer	0.000222	0.0017	CcSEcCtD
Aciclovir—Anorexia—Vincristine—lymphatic system cancer	0.000222	0.0017	CcSEcCtD
Aciclovir—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000221	0.00169	CcSEcCtD
Aciclovir—Body temperature increased—Bleomycin—lymphatic system cancer	0.000221	0.00169	CcSEcCtD
Aciclovir—Insomnia—Carmustine—lymphatic system cancer	0.00022	0.00169	CcSEcCtD
Aciclovir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00022	0.00168	CcSEcCtD
Aciclovir—Irritability—Methotrexate—lymphatic system cancer	0.000219	0.00168	CcSEcCtD
Aciclovir—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000219	0.00168	CcSEcCtD
Aciclovir—Paraesthesia—Carmustine—lymphatic system cancer	0.000219	0.00167	CcSEcCtD
Aciclovir—Hypotension—Vincristine—lymphatic system cancer	0.000217	0.00166	CcSEcCtD
Aciclovir—Dyspnoea—Carmustine—lymphatic system cancer	0.000217	0.00166	CcSEcCtD
Aciclovir—Somnolence—Carmustine—lymphatic system cancer	0.000217	0.00166	CcSEcCtD
Aciclovir—Anorexia—Mitoxantrone—lymphatic system cancer	0.000216	0.00165	CcSEcCtD
Aciclovir—Ataxia—Methotrexate—lymphatic system cancer	0.000216	0.00165	CcSEcCtD
Aciclovir—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000212	0.00162	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000212	0.00162	CcSEcCtD
Aciclovir—Decreased appetite—Carmustine—lymphatic system cancer	0.000212	0.00162	CcSEcCtD
Aciclovir—Hypotension—Mitoxantrone—lymphatic system cancer	0.000212	0.00162	CcSEcCtD
Aciclovir—Insomnia—Vincristine—lymphatic system cancer	0.00021	0.00161	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00021	0.00161	CcSEcCtD
Aciclovir—Paraesthesia—Vincristine—lymphatic system cancer	0.000209	0.0016	CcSEcCtD
Aciclovir—Pain—Carmustine—lymphatic system cancer	0.000208	0.00159	CcSEcCtD
Aciclovir—Constipation—Carmustine—lymphatic system cancer	0.000208	0.00159	CcSEcCtD
Aciclovir—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000207	0.00158	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000206	0.00158	CcSEcCtD
Aciclovir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000206	0.00157	CcSEcCtD
Aciclovir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000203	0.00156	CcSEcCtD
Aciclovir—Decreased appetite—Vincristine—lymphatic system cancer	0.000202	0.00155	CcSEcCtD
Aciclovir—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000202	0.00154	CcSEcCtD
Aciclovir—Somnolence—Mitoxantrone—lymphatic system cancer	0.000201	0.00154	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000201	0.00154	CcSEcCtD
Aciclovir—Feeling abnormal—Carmustine—lymphatic system cancer	0.000201	0.00154	CcSEcCtD
Aciclovir—Fatigue—Vincristine—lymphatic system cancer	0.0002	0.00153	CcSEcCtD
Aciclovir—Asthenia—Bleomycin—lymphatic system cancer	0.0002	0.00153	CcSEcCtD
Aciclovir—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000199	0.00153	CcSEcCtD
Aciclovir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000199	0.00152	CcSEcCtD
Aciclovir—Pain—Vincristine—lymphatic system cancer	0.000199	0.00152	CcSEcCtD
Aciclovir—Constipation—Vincristine—lymphatic system cancer	0.000199	0.00152	CcSEcCtD
Aciclovir—Pruritus—Bleomycin—lymphatic system cancer	0.000197	0.00151	CcSEcCtD
Aciclovir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000197	0.00151	CcSEcCtD
Aciclovir—Fatigue—Mitoxantrone—lymphatic system cancer	0.000195	0.00149	CcSEcCtD
Aciclovir—Pain—Mitoxantrone—lymphatic system cancer	0.000194	0.00148	CcSEcCtD
Aciclovir—Constipation—Mitoxantrone—lymphatic system cancer	0.000194	0.00148	CcSEcCtD
Aciclovir—Abdominal pain—Carmustine—lymphatic system cancer	0.000193	0.00147	CcSEcCtD
Aciclovir—Body temperature increased—Carmustine—lymphatic system cancer	0.000193	0.00147	CcSEcCtD
Aciclovir—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00019	0.00146	CcSEcCtD
Aciclovir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00019	0.00146	CcSEcCtD
Aciclovir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000187	0.00143	CcSEcCtD
Aciclovir—Neutropenia—Methotrexate—lymphatic system cancer	0.000186	0.00142	CcSEcCtD
Aciclovir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000185	0.00142	CcSEcCtD
Aciclovir—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000184	0.00141	CcSEcCtD
Aciclovir—Abdominal pain—Vincristine—lymphatic system cancer	0.000184	0.00141	CcSEcCtD
Aciclovir—Body temperature increased—Vincristine—lymphatic system cancer	0.000184	0.00141	CcSEcCtD
Aciclovir—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000181	0.00139	CcSEcCtD
Aciclovir—Urticaria—Mitoxantrone—lymphatic system cancer	0.00018	0.00138	CcSEcCtD
Aciclovir—Hypersensitivity—Carmustine—lymphatic system cancer	0.000179	0.00137	CcSEcCtD
Aciclovir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000179	0.00137	CcSEcCtD
Aciclovir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000179	0.00137	CcSEcCtD
Aciclovir—Vomiting—Bleomycin—lymphatic system cancer	0.000177	0.00136	CcSEcCtD
Aciclovir—Rash—Bleomycin—lymphatic system cancer	0.000176	0.00135	CcSEcCtD
Aciclovir—Dermatitis—Bleomycin—lymphatic system cancer	0.000176	0.00135	CcSEcCtD
Aciclovir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000175	0.00134	CcSEcCtD
Aciclovir—Asthenia—Carmustine—lymphatic system cancer	0.000175	0.00134	CcSEcCtD
Aciclovir—Renal failure—Methotrexate—lymphatic system cancer	0.000174	0.00133	CcSEcCtD
Aciclovir—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000172	0.00132	CcSEcCtD
Aciclovir—Hypersensitivity—Vincristine—lymphatic system cancer	0.000171	0.00131	CcSEcCtD
Aciclovir—Haematuria—Methotrexate—lymphatic system cancer	0.000169	0.00129	CcSEcCtD
Aciclovir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000167	0.00128	CcSEcCtD
Aciclovir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000167	0.00128	CcSEcCtD
Aciclovir—Asthenia—Vincristine—lymphatic system cancer	0.000167	0.00128	CcSEcCtD
Aciclovir—Diarrhoea—Carmustine—lymphatic system cancer	0.000167	0.00128	CcSEcCtD
Aciclovir—Nausea—Bleomycin—lymphatic system cancer	0.000166	0.00127	CcSEcCtD
Aciclovir—Asthenia—Mitoxantrone—lymphatic system cancer	0.000162	0.00124	CcSEcCtD
Aciclovir—Dizziness—Carmustine—lymphatic system cancer	0.000161	0.00123	CcSEcCtD
Aciclovir—Diarrhoea—Vincristine—lymphatic system cancer	0.000159	0.00122	CcSEcCtD
Aciclovir—Hepatitis—Methotrexate—lymphatic system cancer	0.000159	0.00122	CcSEcCtD
Aciclovir—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000157	0.0012	CcSEcCtD
Aciclovir—Urethral disorder—Methotrexate—lymphatic system cancer	0.000156	0.00119	CcSEcCtD
Aciclovir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000155	0.00119	CcSEcCtD
Aciclovir—Vomiting—Carmustine—lymphatic system cancer	0.000155	0.00119	CcSEcCtD
Aciclovir—Dizziness—Vincristine—lymphatic system cancer	0.000154	0.00118	CcSEcCtD
Aciclovir—Rash—Carmustine—lymphatic system cancer	0.000154	0.00118	CcSEcCtD
Aciclovir—Dermatitis—Carmustine—lymphatic system cancer	0.000153	0.00117	CcSEcCtD
Aciclovir—Headache—Carmustine—lymphatic system cancer	0.000153	0.00117	CcSEcCtD
Aciclovir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00015	0.00115	CcSEcCtD
Aciclovir—Eye disorder—Methotrexate—lymphatic system cancer	0.000148	0.00114	CcSEcCtD
Aciclovir—Vomiting—Vincristine—lymphatic system cancer	0.000148	0.00113	CcSEcCtD
Aciclovir—Rash—Vincristine—lymphatic system cancer	0.000147	0.00112	CcSEcCtD
Aciclovir—Dermatitis—Vincristine—lymphatic system cancer	0.000146	0.00112	CcSEcCtD
Aciclovir—Headache—Vincristine—lymphatic system cancer	0.000146	0.00111	CcSEcCtD
Aciclovir—Nausea—Carmustine—lymphatic system cancer	0.000145	0.00111	CcSEcCtD
Aciclovir—Vomiting—Mitoxantrone—lymphatic system cancer	0.000144	0.0011	CcSEcCtD
Aciclovir—Immune system disorder—Methotrexate—lymphatic system cancer	0.000143	0.0011	CcSEcCtD
Aciclovir—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000143	0.0011	CcSEcCtD
Aciclovir—Rash—Mitoxantrone—lymphatic system cancer	0.000143	0.00109	CcSEcCtD
Aciclovir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000143	0.00109	CcSEcCtD
Aciclovir—Chills—Methotrexate—lymphatic system cancer	0.000142	0.00109	CcSEcCtD
Aciclovir—Headache—Mitoxantrone—lymphatic system cancer	0.000142	0.00109	CcSEcCtD
Aciclovir—Alopecia—Methotrexate—lymphatic system cancer	0.00014	0.00107	CcSEcCtD
Aciclovir—Erythema—Methotrexate—lymphatic system cancer	0.000138	0.00106	CcSEcCtD
Aciclovir—Nausea—Vincristine—lymphatic system cancer	0.000138	0.00106	CcSEcCtD
Aciclovir—Dysgeusia—Methotrexate—lymphatic system cancer	0.000135	0.00104	CcSEcCtD
Aciclovir—Nausea—Mitoxantrone—lymphatic system cancer	0.000134	0.00103	CcSEcCtD
Aciclovir—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000128	0.000982	CcSEcCtD
Aciclovir—Anaemia—Methotrexate—lymphatic system cancer	0.000128	0.000978	CcSEcCtD
Aciclovir—Malaise—Methotrexate—lymphatic system cancer	0.000125	0.000954	CcSEcCtD
Aciclovir—Vertigo—Methotrexate—lymphatic system cancer	0.000124	0.00095	CcSEcCtD
Aciclovir—Leukopenia—Methotrexate—lymphatic system cancer	0.000124	0.000947	CcSEcCtD
Aciclovir—Convulsion—Methotrexate—lymphatic system cancer	0.00012	0.000917	CcSEcCtD
Aciclovir—Arthralgia—Methotrexate—lymphatic system cancer	0.000118	0.000901	CcSEcCtD
Aciclovir—Myalgia—Methotrexate—lymphatic system cancer	0.000118	0.000901	CcSEcCtD
Aciclovir—Chest pain—Methotrexate—lymphatic system cancer	0.000118	0.000901	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000117	0.000894	CcSEcCtD
Aciclovir—Discomfort—Methotrexate—lymphatic system cancer	0.000116	0.00089	CcSEcCtD
Aciclovir—Confusional state—Methotrexate—lymphatic system cancer	0.000114	0.000871	CcSEcCtD
Aciclovir—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000113	0.000863	CcSEcCtD
Aciclovir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000111	0.000847	CcSEcCtD
Aciclovir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00011	0.000845	CcSEcCtD
Aciclovir—Skin disorder—Methotrexate—lymphatic system cancer	0.00011	0.000839	CcSEcCtD
Aciclovir—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000109	0.000835	CcSEcCtD
Aciclovir—Anorexia—Methotrexate—lymphatic system cancer	0.000108	0.000823	CcSEcCtD
Aciclovir—Hypotension—Methotrexate—lymphatic system cancer	0.000105	0.000807	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000103	0.000787	CcSEcCtD
Aciclovir—Insomnia—Methotrexate—lymphatic system cancer	0.000102	0.000781	CcSEcCtD
Aciclovir—Paraesthesia—Methotrexate—lymphatic system cancer	0.000101	0.000775	CcSEcCtD
Aciclovir—Dyspnoea—Methotrexate—lymphatic system cancer	0.000101	0.00077	CcSEcCtD
Aciclovir—Somnolence—Methotrexate—lymphatic system cancer	0.0001	0.000768	CcSEcCtD
Aciclovir—Dyspepsia—Methotrexate—lymphatic system cancer	9.93e-05	0.00076	CcSEcCtD
Aciclovir—Decreased appetite—Methotrexate—lymphatic system cancer	9.81e-05	0.000751	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	9.74e-05	0.000745	CcSEcCtD
Aciclovir—Fatigue—Methotrexate—lymphatic system cancer	9.73e-05	0.000744	CcSEcCtD
Aciclovir—Pain—Methotrexate—lymphatic system cancer	9.65e-05	0.000738	CcSEcCtD
Aciclovir—Feeling abnormal—Methotrexate—lymphatic system cancer	9.3e-05	0.000711	CcSEcCtD
Aciclovir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	9.22e-05	0.000706	CcSEcCtD
Aciclovir—Urticaria—Methotrexate—lymphatic system cancer	8.96e-05	0.000686	CcSEcCtD
Aciclovir—Abdominal pain—Methotrexate—lymphatic system cancer	8.92e-05	0.000683	CcSEcCtD
Aciclovir—Body temperature increased—Methotrexate—lymphatic system cancer	8.92e-05	0.000683	CcSEcCtD
Aciclovir—Hypersensitivity—Methotrexate—lymphatic system cancer	8.31e-05	0.000636	CcSEcCtD
Aciclovir—Asthenia—Methotrexate—lymphatic system cancer	8.09e-05	0.000619	CcSEcCtD
Aciclovir—Pruritus—Methotrexate—lymphatic system cancer	7.98e-05	0.000611	CcSEcCtD
Aciclovir—Diarrhoea—Methotrexate—lymphatic system cancer	7.72e-05	0.000591	CcSEcCtD
Aciclovir—Dizziness—Methotrexate—lymphatic system cancer	7.46e-05	0.000571	CcSEcCtD
Aciclovir—Vomiting—Methotrexate—lymphatic system cancer	7.17e-05	0.000549	CcSEcCtD
Aciclovir—Rash—Methotrexate—lymphatic system cancer	7.11e-05	0.000544	CcSEcCtD
Aciclovir—Dermatitis—Methotrexate—lymphatic system cancer	7.11e-05	0.000544	CcSEcCtD
Aciclovir—Headache—Methotrexate—lymphatic system cancer	7.07e-05	0.000541	CcSEcCtD
Aciclovir—Nausea—Methotrexate—lymphatic system cancer	6.7e-05	0.000513	CcSEcCtD
